The p38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1β on long-term potentiation in the rat dentate gyrus in vitro
The DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
Abstract
Levels of the pro-inflammatory cytokine interleukin-1beta are known to be elevated in patients with chronic disorders such as Alzheimer's disease. We have investigated the effects of interleukin-1beta on long-term potentiation and N-methyl-D-aspartate receptor-mediated field potentials in the rat dentate gyrus in vitro utilizing field extracellular recordings obtained from the middle third of the molecular layer of the dentate gyrus. Presynaptic stimulation was applied to the commissural/association pathway at a frequency of 0.05 Hz and at a distance of 50 microm from the granule cell body layer. As previously reported, interleukin-1beta (1 ng/ml) caused an inhibition of long-term potentiation (108+/-2% of baseline 1 h following application of tetanic stimulation compared with 145+/-5% in vehicle control slices). This action of interleukin-1beta on long-term potentiation, as well as an inhibition of N-methyl-D aspartate receptor-mediated field potentials, was attenuated by pre-treatment of slices with the p38 mitogen-associated protein kinase inhibitor SB203580 (1 microM). SB203580 alone had no significant affect on long-term potentiation, but did cause an increase in baseline synaptic transmission [107+/-2% of baseline, 1 h after SB203580 (1 microM) treatment]. The p42/44 mitogen-activated protein kinase cascade inhibitor PD98059 (50 microM) did not inhibit the interleukin-1beta-induced inhibition of N-methyl-D-aspartate receptor-mediated field potentials. The cyclooxygenase inhibitor indomethacin (50 microM) was found to attenuate the interleukin-1beta-induced effects on both long-term potentiation and N-methyl-D-aspartate receptor-mediated field potentials. The lipid second messenger analogue C2 ceramide (20 microM) was found to attenuate the expression of long-term potentiation (108+/-3% of baseline 1 h following tetanic stimulation), and this effect was not blocked by pre-treatment with SB203580. To investigate a possible role for interleukin-1beta in the normal expression of long-term potentiation, the interleukin-1 receptor antagonist (25 ng/ml) was applied during the maintenance phase of long-term potentiation. This was found to depress the sustained expression of long-term potentiation (116+/-6% of baseline 1 h following tetanic stimulation). Our results indicate possible signalling mechanisms by which interleukin-1beta at pathophysiological concentrations may serve to inhibit long-term potentiation, and also suggests a role for IL-1beta in the physiological expression of synaptic plasticity in the rat dentate gyrus in vitro.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-1b is also an inhibitor of NMDAR-mediated long-term potentiation (LTP), likely through a MAP kinase mechanism”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Coogan et al., 1999
Citations
Cites
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)00357-f · Cited by 2,086
cPLA2 is phosphorylated and activated by MAP kinase
Lin, L.-L., Wartmann, M., Lin, A. Y., Knopf, J. L., Seth, A., & Davis, R. J. (1993) · Cell · doi:10.1016/0092-8674(93)90666-e · Cited by 1,849
Sounding the Alarm: Protein Kinase Cascades Activated by Stress and Inflammation
Kyriakis, J. M., & Avruch, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24313 · Cited by 1,084
Cytokines and the nervous system II: actions and mechanisms of action
Rothwell, N. J., & Hopkins, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93890-a · Cited by 923
Pang, L., Sawada, T., Decker, S. J., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13585 · Cited by 896
Structural Changes Accompanying Memory Storage
Bailey, C. H., & Kandel, E. R. (1993) · Annual Review of Physiology · doi:10.1146/annurev.ph.55.030193.002145 · Cited by 860
A Requirement for the Mitogen-activated Protein Kinase Cascade in Hippocampal Long Term Potentiation
English, J. D., & Sweatt, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19103 · Cited by 855
Research works printed but not linked: 2
- Furaya, 1997, Ceramide activates JNK/SAPK in cerebellar neurons, Soc. Neurosci. Abstr., 27, 466.6
- Seger, 1995, The MAPK signalling cascade, Fedn Am. Socs exp. Biol. J., 9, 726
Cited by
Immune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
“…of IL-1ra 30 min after the induction of LTP in the rat DG in vitro reduced synaptic activity back to baseline levels (Coogan et al., 1999), and when IL-1ra was applied to hippocampal sliced in a physiological temperature for 40 min before stimulation, the initial…”
BackgroundMethodResultInfluentialInflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
“Additionally, IL-1b is also an inhibitor of NMDAR-mediated long-term potentiation (LTP), likely through a MAP kinase mechanism (Coogan et al., 1999), as is IL-18 (Curran and O'Connor, 2001).”
BackgroundEvidence for a cytokine model of cognitive function
McAfoose, J., & Baune, B. T. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.10.005 · Cited by 760
“Subsequent work (i.e. Coogan et al., 1999; Ross et al., 2003) has confirmed that at least under physiological conditions IL-1b is required for LTP maintenance, whereas, higher concentration of IL-1b, under pathophysiological conditions, inhibits LTP.”
BackgroundDunne, A., & O'Neill, L. A. J. (2003) · Science's STKE · doi:10.1126/stke.2003.171.re3 · Cited by 711
“where IL-1 has been shown to be important (74, 75).”
BackgroundSelf-citation“Inflammatory” Cytokines: Neuromodulators in Normal Brain?
Vitkovic, L., Bockaert, J., & Jacque, C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740457.x · Cited by 506
Metadata
- Authors
- Coogan, A. N., O'Neill, L. A. J., & O'Connor, J. J.
- Affiliations
- University College Dublin (IE)
- Trinity College Dublin (IE)
- Corresponding author
- O'Connor, J.J.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1999-06
- Volume
- 93
- Issue
- 1
- Pages
- 57-69
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W1977463464
- Cited by
- 129
- References
- 63
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 2 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 1 · 2015: 7 · 2014: 9 · 2013: 6 · 2012: 4
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Health Research Board
- University College Dublin
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- IL-1β, long-term potentiation, p38 MAPK, SB203580, dentate gyrus, NMDA receptor, field potentials, synaptic transmission, indomethacin, cyclooxygenase, C2-ceramide, interleukin-1 receptor antagonist, Alzheimer's disease, neuroinflammation, synaptic plasticity, p44/42 MAPK
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Enzyme Inhibitors, Flavonoids, Imidazoles, Indomethacin, Interleukin-1, Male, Synaptic Transmission, Pyridines, Receptors, N-Methyl-D-Aspartate, Rats, Wistar, Long-Term Potentiation, Calcium-Calmodulin-Dependent Protein Kinases, Dentate Gyrus, Perforant Pathway, Excitatory Postsynaptic Potentials, Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The p38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1β on long-term potentiation in the rat dentate gyrus in vitro. https://app.cochat.ai/papers/10.1016/s0306-4522(99)00100-1
- The paper
- Coogan, A. N., O'Neill, L. A. J., & O'Connor, J. J. (1999). The p38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1β on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience. https://doi.org/10.1016/s0306-4522(99)00100-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.